12.04 - Rare ILD/DPLD 2022
DOI: 10.1183/13993003.congress-2022.4062
|View full text |Cite
|
Sign up to set email alerts
|

Survival and mortality associated factors in progressive fibrosing interstitial disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The prevalence of this form of ILD in approximately 30% for all types of ILD other than IPF [ 13 , 14 ]. The most concerning aspect of PF-ILD presents with poor prognosis similar to IPF [ 15 ]. ILDs that can progress to becoming PF-ILD are non-autoimmune-related (50.0%), autoimmune-related (40.0%) and sarcoidosis (10.0%) [ 16 ].…”
Section: Introductionmentioning
confidence: 99%
“…The prevalence of this form of ILD in approximately 30% for all types of ILD other than IPF [ 13 , 14 ]. The most concerning aspect of PF-ILD presents with poor prognosis similar to IPF [ 15 ]. ILDs that can progress to becoming PF-ILD are non-autoimmune-related (50.0%), autoimmune-related (40.0%) and sarcoidosis (10.0%) [ 16 ].…”
Section: Introductionmentioning
confidence: 99%